Janux is a biotech company developing next-generation therapeutics. Keeping up with SEC guidance with a relatively small team while consistently delivering quarterly reports was becoming a challenge. New ActiveDisclosure enabled Janux to deliver on-time and accurate SEC filing with unparalleled expertise and service.
Case Studies & Fact Sheets
